192 related articles for article (PubMed ID: 11407945)
1. The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
Bardeesy N; Sharpless NE; DePinho RA; Merlino G
Semin Cancer Biol; 2001 Jun; 11(3):201-18. PubMed ID: 11407945
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer biology and genetics.
Bardeesy N; DePinho RA
Nat Rev Cancer; 2002 Dec; 2(12):897-909. PubMed ID: 12459728
[TBL] [Abstract][Full Text] [Related]
3. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
Clark CE; Beatty GL; Vonderheide RH
Cancer Lett; 2009 Jun; 279(1):1-7. PubMed ID: 19013709
[TBL] [Abstract][Full Text] [Related]
4. The molecular genetics of pancreatic ductal carcinoma.
Sohn TA
Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
[TBL] [Abstract][Full Text] [Related]
5. [Precursors to pancreatic cancer].
Søreide K; Immervoll H; Molven A
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881
[TBL] [Abstract][Full Text] [Related]
6. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of pancreatic tumor metastasis in transgenic immunodeficient mice.
Gallo-Hendrikx E; Copps J; Percy D; Croy BA; Wildeman AG
Oncogene; 1994 Oct; 9(10):2983-90. PubMed ID: 8084602
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods.
Eskelinen MJ; Haglund UH
Eur J Surg; 1999 Apr; 165(4):292-306. PubMed ID: 10365829
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
Logsdon CD; Simeone DM; Binkley C; Arumugam T; Greenson JK; Giordano TJ; Misek DE; Kuick R; Hanash S
Cancer Res; 2003 May; 63(10):2649-57. PubMed ID: 12750293
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
11. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma -- genetic portrait from chromosomes to microarrays.
Karhu R; Mahlamäki E; Kallioniemi A
Genes Chromosomes Cancer; 2006 Aug; 45(8):721-30. PubMed ID: 16688744
[TBL] [Abstract][Full Text] [Related]
13. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic basis of pancreatic adenocarcinoma.
Hilgers W; Kern SE
Genes Chromosomes Cancer; 1999 Sep; 26(1):1-12. PubMed ID: 10440999
[TBL] [Abstract][Full Text] [Related]
15. Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.
Kasper S
J Cell Biochem; 2005 Feb; 94(2):279-97. PubMed ID: 15565647
[TBL] [Abstract][Full Text] [Related]
16. Molecular changes in pancreatic cancer.
Buchholz M; Gress TM
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1487-97. PubMed ID: 19828010
[TBL] [Abstract][Full Text] [Related]
17. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
18. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
19. [Biological aspects of pancreatic cancer].
Tonel E; Carbone A; Scirelli T; Bellone G; Emanuelli G
Minerva Med; 2005 Apr; 96(2):87-94. PubMed ID: 16172578
[TBL] [Abstract][Full Text] [Related]
20. Development of the pancreas and pancreatic cancer.
Lewis BC
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):397-404, xi. PubMed ID: 16632101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
